PharmaBlock Sciences (Nanjing), Inc.

SZSE:300725.SZ

39.57 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013
Revenue 1,706.5721,594.71,201.6291,022.229662.231478.254273.251188.378136.13176.63958.547
Cost of Revenue 1,029.744869.498623.343554.169320.574201.744103.51363.36752.9125.48517.61
Gross Profit 676.828725.202578.286468.06341.657276.51169.738125.01183.22151.15440.937
Gross Profit Ratio 0.3970.4550.4810.4580.5160.5780.6210.6640.6110.6670.699
Reseach & Development Expenses 155.956168.324114.02490.92769.22144.3524.73216.3078.9877.4486.958
General & Administrative Expenses 65.01771.93566.55966.98625.57916.45914.37228.38828.4053.8982.452
Selling & Marketing Expenses 53.20740.95624.28530.66224.25420.67817.64411.7174.4662.6111.945
SG&A 238.528112.89190.84397.64749.83337.13732.01740.10532.8726.5084.397
Other Expenses -23.12147.48392.06860.54855.74411.4292.9383.9352.761.8191.026
Operating Expenses 417.604428.698296.935249.123174.798132.31188.90684.02260.71725.80819.998
Operating Income 259.224296.706492.956194.127163.536142.97774.12240.77424.13524.64620.557
Operating Income Ratio 0.1520.1860.410.190.2470.2990.2710.2160.1770.3220.351
Total Other Income Expenses Net -36.12826.55814.81310.3788.81510.207-3.7713.6644.3921.0070.644
Income Before Tax 223.096323.263507.769204.505172.351154.40677.0644.65326.89626.35321.583
Income Before Tax Ratio 0.1310.2030.4230.20.260.3230.2820.2370.1980.3440.369
Income Tax Expense 24.014-2.6274.00320.320.27919.9079.2729.6097.0383.8963.336
Net Income 197.361314.224486.559184.208152.069133.36367.17936.11519.93422.47118.247
Net Income Ratio 0.1160.1970.4050.180.230.2790.2460.1920.1460.2930.312
EPS 0.991.572.450.990.820.720.470.270.180.530.17
EPS Diluted 0.981.572.440.750.820.720.470.270.180.530.17
EBITDA 380.805466.054581.783236.738201.883177.55791.96157.47231.35631.11124.829
EBITDA Ratio 0.2230.2920.4840.2320.3050.3710.3370.3050.230.4060.424